Regulations.gov document
Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide…
Rule · FDA-2008-N-0039 · posted Mar 10, 2008
Key facts
| Document ID | FDA-2008-N-0039-0016 |
|---|---|
| Title | Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide Injection; Gleptoferron Injection; Iron Dextran Complex Injection; Iron Hydrogenated Dextran Injection |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2008-N-0039 |
| Posted | Mar 10, 2008 |
| Federal Register citation | 73FR12634 |
| FR document number | E8-04603 |
| CFR | 21 CFR 522 |
| Comment period opens | Mar 10, 2008 |
| Effective date | Mar 10, 2008 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: